Registration fees:       $175 per NDHA member  |  $225 per non-member

TARGET AUDIENCE:

Chief Medical Officer, Chief Nursing Officer, Compliance Officer, Emergency Department Personnel, Joint Commission Coordinator, Medical Records, Quality Improvement personnel, Risk Manager, and Legal Counsel.

OVERVIEW:

The Institute for Safe Medication Practices (ISMP) recently published its annual “Top 10 Medication Safety Concerns” on medication errors and hazards. The top four involve COVID-19 vaccines, including formula and preparation errors as well as administration errors. Supply chain issues related to the availability of hypertonic saline was also one of the top concerns. The key issue was timely availability of the solution for prompt treatment of potential life-threatening conditions, such as cerebral edema. Other concerns that made the list were discontinued or paused infusions infection transmission with shared glucometers, and adverse glycemic events. Additionally, ISMP urges every facility to have a medication safety officer. This individual can serve as a medication safety advocate while addressing medication safety concerns to hospital leadership. This webinar will review the Centers for Disease Control and Prevention (CDC) opioid guidelines, Joint Commission final pain management guidelines, federal guidelines for opioid programs, opioid epidemic, and required hospital policies and training. The Centers for Medicare & Medicaid Services (CMS) standards on the care of the patient receiving opioids will also be addressed. This session will also discuss the ISMP IV Push guidelines for adults and the National Action Plan for ADR prevention related to the opioid recommendations. The CMS final worksheet on tracking medication administration errors and adverse drug reactions will be covered and the CDC final opioid guidelines will be reviewed.

• Recall the ISMP Top 10 Medication Errors and hazards.
• Discuss ISMP’s recommendations for safe administration of COVID-19 and othervaccinations, including dealing with leftover doses.
• Review ISMP recommendations to prevent transmission of infections.
• Recite the importance of a medication safety officer for a facility.
• Recall that CMS has required policies and education requirements on medication administration.

SPEAKER:

A speaker from Nash Healthcare Consulting will be identified soon.